These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27005968)

  • 41. A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.
    Narimatsu H; Sawaki H; Kuno A; Kaji H; Ito H; Ikehara Y
    FEBS J; 2010 Jan; 277(1):95-105. PubMed ID: 19919546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glycoproteomic strategies: From discovery to clinical application of cancer carbohydrate biomarkers.
    Ueda K
    Proteomics Clin Appl; 2013 Oct; 7(9-10):607-17. PubMed ID: 23640819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ubiquitous Importance of Protein Glycosylation.
    Krištić J; Lauc G
    Methods Mol Biol; 2017; 1503():1-12. PubMed ID: 27743354
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigating the biomarker potential of glycoproteins using comparative glycoprofiling - application to tissue inhibitor of metalloproteinases-1.
    Thaysen-Andersen M; Thøgersen IB; Lademann U; Offenberg H; Giessing AM; Enghild JJ; Nielsen HJ; Brünner N; Højrup P
    Biochim Biophys Acta; 2008 Mar; 1784(3):455-63. PubMed ID: 18206988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
    Taniguchi N; Kizuka Y
    Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.
    Satomaa T; Heiskanen A; Leonardsson I; Angström J; Olonen A; Blomqvist M; Salovuori N; Haglund C; Teneberg S; Natunen J; Carpén O; Saarinen J
    Cancer Res; 2009 Jul; 69(14):5811-9. PubMed ID: 19584298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Site-specific glycoproteomics confirms that protein structure dictates formation of N-glycan type, core fucosylation and branching.
    Thaysen-Andersen M; Packer NH
    Glycobiology; 2012 Nov; 22(11):1440-52. PubMed ID: 22798492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Defining glycoprotein cancer biomarkers by MS in conjunction with glycoprotein enrichment.
    Song E; Mechref Y
    Biomark Med; 2015; 9(9):835-44. PubMed ID: 26330015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploring human glycosylation for better therapies.
    Krasnova L; Wong CH
    Mol Aspects Med; 2016 Oct; 51():125-43. PubMed ID: 27178988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential glycan analysis of an endogenous glycoprotein: toward clinical implementation--from sample pretreatment to data standardization.
    Kuno A; Matsuda A; Unno S; Tan B; Hirabayashi J; Narimatsu H
    Methods Mol Biol; 2014; 1200():265-85. PubMed ID: 25117242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lectin approaches for glycoproteomics in FDA-approved cancer biomarkers.
    Badr HA; Alsadek DM; Darwish AA; Elsayed AI; Bekmanov BO; Khussainova EM; Zhang X; Cho WC; Djansugurova LB; Li CZ
    Expert Rev Proteomics; 2014 Apr; 11(2):227-36. PubMed ID: 24611567
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tailored glycoproteomics and glycan site mapping using saccharide-selective bioorthogonal probes.
    Hanson SR; Hsu TL; Weerapana E; Kishikawa K; Simon GM; Cravatt BF; Wong CH
    J Am Chem Soc; 2007 Jun; 129(23):7266-7. PubMed ID: 17506567
    [No Abstract]   [Full Text] [Related]  

  • 53. Aiming at the sweet side of cancer: aberrant glycosylation as possible target for personalized-medicine.
    Padler-Karavani V
    Cancer Lett; 2014 Sep; 352(1):102-12. PubMed ID: 24141190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycobiomarkers by glycoproteomics and glycan profiling (glycomics): emergence of functionality.
    Gabius HJ
    Biochem Soc Trans; 2011 Jan; 39(1):399-405. PubMed ID: 21265812
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NanoMonitor: a miniature electronic biosensor for glycan biomarker detection.
    Nagaraj VJ; Aithal S; Eaton S; Bothara M; Wiktor P; Prasad S
    Nanomedicine (Lond); 2010 Apr; 5(3):369-78. PubMed ID: 20394531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential binding to glycotopes among the layers of three mammalian retinal neurons by man-containing N-linked glycan, T(alpha) (Galbeta1-3GalNAcalpha1-), Tn (GalNAcalpha1-Ser/Thr) and I (beta)/II (beta) (Galbeta1-3/4GlcNAcbeta-) reactive lectins.
    Wu WC; Lai CC; Liu JH; Singh T; Li LM; Peumans WJ; Van Damme EJ; Wu AM
    Neurochem Res; 2006 May; 31(5):619-28. PubMed ID: 16770733
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intramolecular N-glycan/polypeptide interactions observed at multiple N-glycan remodeling steps through [(13)C,(15)N]-N-acetylglucosamine labeling of immunoglobulin G1.
    Barb AW
    Biochemistry; 2015 Jan; 54(2):313-22. PubMed ID: 25551295
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential glycan profiling by lectin microarray targeting tissue specimens.
    Kuno A; Matsuda A; Ikehara Y; Narimatsu H; Hirabayashi J
    Methods Enzymol; 2010; 478():165-79. PubMed ID: 20816479
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative study on the purification of the Amaranthus leucocarpus syn. hypocondriacus lectin.
    Hernández P; Bacilio M; Porras F; Juarez S; Debray H; Zenteno E; Ortiz B
    Prep Biochem Biotechnol; 1999 Aug; 29(3):219-34. PubMed ID: 10431927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression.
    Brooks SA
    Histol Histopathol; 2000 Jan; 15(1):143-58. PubMed ID: 10668205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.